Hexicon AB

As of June 30, 2026, Hexicon AB carries a market capitalization of 47.11M, placing it among publicly traded companies globally. Its enterprise value stands at 984.61M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Hexicon AB's next confirmed earnings release is scheduled for November 26, 2026.

As of June 30, 2026, Hexicon AB has 363.80M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 4.53, and the price-to-book ratio stands at -0.08.

These figures are as of June 30, 2026. The EV/Sales ratio of 94.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 984.61M versus a market cap of 47.11M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Hexicon AB maintains a current ratio of 1.86, meaning it holds 1.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -150.64, indicating conservative leverage, while an interest coverage ratio of -0.29 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -72.99, reflecting losses generated across the asset base. The company generates approximately 495,238.10 in revenue per employee across its workforce of 21.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Hexicon AB recorded 600,000.00 in income tax expense. The company reported a pretax loss of -360.80M and -361.50M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Hexicon AB's stock has declined approximately 39.74% over the past 52 weeks. The 50-day moving average sits at 0.11, while the 200-day moving average is 0.14.

Over the twelve months ended June 30, 2026, Hexicon AB generated 10.40M in revenue and converted that into -361.50M in net income, yielding earnings per share of -0.99. EBITDA reached -59.40M, while operating income came in at -183.90M.

As of June 30, 2026, Hexicon AB holds 3.30M in cash and equivalents against 941.50M in total debt, resulting in a net debt position of 938.20M. Total book value stands at -624.30M, with working capital of 132.30M providing operational flexibility.

Hexicon AB produced -54.50M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.40M in capital expenditures, free cash flow totaled -60.90M - equivalent to -0.17 per share.

These figures cover the twelve months ended June 30, 2026. The operating margin of -1,768.27 and net profit margin of -3,475.96 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -129.27: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -112.07, meaning Hexicon AB raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Hexicon AB has an Altman Z-Score of -5.34, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.